Tag: Immunoglobulin G (IgG)

Jessica Grossman

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...
Boy Contemplating a Peanut

Why Immunotherapy for Peanut Allergy Works for Some, Not Everyone

Researchers make progress in peanut allergy immunotherapy using a new approach.
RNA and Tree Nut Allergy

IgGenix Shows Potential of Platform to Advance Understanding of Tree Nut...

The company is aiming at more targeted therapeutic approaches that have the potential to address key allergens directly.
AllerSmart IgE

IgE Allergy Test for Top 9 Food Allergens Now Available for...

Screen for allergies to foods and 29 common environmental allergens.
Food Sensitivity Test

Home Food Intolerance/Sensitivity Tests: Don’t Buy Into the Hype

You've probably noticed tons of ads for at-home food intolerance testing. What's that all about and should you look into it?
COVID-19 Vaccine Vials

Gradual Doses Used to Vaccinate People Allergic to Their First Dose...

Graded dosing protocol may help patients with first dose reactions tolerate second dose of vaccine.
Palforzia Capsules with Logo

Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...

Majority of patients experienced low rates of adverse events which declined in frequency and severity with continued treatment.
IgG Antibody

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode

IgGenix will develop a therapy that focuses on all types of food allergies and related conditions.
Dr Kari Nadeau

Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...

Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour of food...
Moo

Test is 87% Accurate at Determining Outcome to Milk OIT

Using a growing database of patient reactivity signatures can better predict milk-allergic patient outcomes compared to traditional methods.